MITRA-FR
2018
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
In 304 patients with heart failure and severe secondary mitral regurgitation, transcatheter mitral repair did not reduce death or heart-failure hospitalisation compared with medical therapy alone.
Result
Efficacy: Death or HF hospitalisation at 12 monthsOR 1.16 (95% CI 0.73-1.84) · P = 0.53
Below 1 favours transcatheter mitral repair, above 1 favours medical therapy alone.
- Absolute difference
- 3.3 points
The absolute difference is derived from the event rates.
- Subtopic
- Mitral
- Design
- Open-label RCT, 1 yr
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2025 VHDACC/AHA 2020 VHD
- Source
- Obadia JF, et al. N Engl J Med. 2018;379(24):2297-2306.doi 10.1056/NEJMoa1805374
Discussion & critique
Negative where COAPT was positive, explained by patient selection: 'proportionate' MR with larger ventricles. The EROA/LVEDV ratio helps identify who benefits from repair.